scispace - formally typeset
J

Jinshan Wu

Researcher at Chongqing Medical University

Publications -  13
Citations -  138

Jinshan Wu is an academic researcher from Chongqing Medical University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 8 publications receiving 50 citations.

Papers
More filters
Journal ArticleDOI

A Novel Visceral Adiposity Index for Prediction of Type 2 Diabetes and Pre-diabetes in Chinese adults: A 5-year prospective study

TL;DR: The data demonstrate that the CVAI is a better predictor of type 2 diabetes and pre-diabetes than the VAI, BMI, waist circumference, waist- to-hip ratio and waist-to-height ratio in Chinese adults.
Journal ArticleDOI

Increased β-Cell Mass in Obese Rats after Gastric Bypass: A Potential Mechanism for Improving Glycemic Control.

TL;DR: RYGB induced improved glycemic control and enhanced β-Cell function, which was reflected in a better glucose tolerance and a rapidly increased secretion of insulin and C-peptide after glucose administration, which indicates that RYGB can improve β- Cell function via increasingβ-Cell mass, which plays a key role in improved gly glucose control after RY GB.
Journal ArticleDOI

Relationship Between the TyG Index and Diabetic Kidney Disease in Patients with Type-2 Diabetes Mellitus

TL;DR: In this article, the authors investigated if the TyG Index can predict the onset of Type-2 Diabetes mellitus (T2DM) in 1432 T2DM patients and found that patients with a higher TyG index had a higher risk of microalbuminuria and estimated glomerular filtration rate (eGFR) 30 mg/mL.
Journal ArticleDOI

Kidney single-cell transcriptome profile reveals distinct response of proximal tubule cells to SGLT2i and ARB treatment in diabetic mice.

TL;DR: In this article, the authors conducted single-cell RNA sequencing to profile the kidney cell transcriptome of db/db mice treated with vehicle, ARBs, SGLT2i, or ARBs plus SGLTs 2 inhibitors, using db/m mice as control.
Journal ArticleDOI

Early-Onset Type 2 Diabetes as a Risk Factor for End-Stage Renal Disease in Patients With Diabetic Kidney Disease

TL;DR: In patients with DKD, early-onset type 2 diabetes is an independent risk factor of end-stage renal disease (ESRD), and the risk of ESRD after adjusting for sex, traditional metabolic factors, drug factors, and diabetes duration is still high.